Search clinical trials for: JS001 120mg GP

Total 2091 results

Peking University Cancer Hospital & Institute

Unknown

A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer

Urothelial Carcinoma

China
Novavax

Completed

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Ebola

Australia
Epicentre
Medecins Sans Frontieres, Netherlands

Completed

Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

Ebola Virus Disease

Uganda, Congo, The Democratic Republic of the
Poznan University of Medical Sciences

Completed

Oxycodone (10, 20 mg) in a Postoperative Dressing

Burns
Universitätsklinikum Hamburg-Eppendorf
Federal Joint Committee

Completed

Enhancing the Clinical Effectiveness of Depression Screening Using Patient-targeted Feedback in General Practices

Depression

Germany
MitoImmune Therapeutics

Completed

Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects

Heathly Subjects

Korea, Republic of
New Cancer Cure-Bio Co.,Ltd.

Recruiting

Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713

Advanced Solid Tumors

Korea, Republic of
Groupe Francophone des Myelodysplasies
Advancell - Advanced In Vitro Cell Technologies, S.A.

Terminated

GFM-Acadesine: A Phase I-II Trial of Acadesine (Acadesine)

SMD

France
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Clinical Study of JS007 in Patients With Advanced Solid Tumors

Patients With Advanced Solid Tumors

China
Shanghai Junshi Bioscience Co., Ltd.
Sponsor GmbH

Active, not recruiting

A Pharmacokinetic Study of JS002 in Healthy Subjects

Health Volunteer

China
Peking Union Medical College Hospital

Not yet recruiting

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

Oral Squamous Cell Carcinoma

China
Cancer Hospital of Guangxi Medical University

Recruiting

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma

China
Shanghai Junshi Bioscience Co., Ltd.
Sponsor GmbH

Withdrawn

JS001+IMP4297 in Patients With Advanced Cancer

Advanced Cancer
University of British Columbia
Canadian Institutes of Health Research (CIHR); Canadian Mental Health Association

Unknown

Evaluation of the Bounce Back Program

Depression

Canada
GlaxoSmithKline

Withdrawn

GSK2190915 Pediatric Study

Asthma
Jinling Hospital, China

Recruiting

A Study of RC48-ADC Combined With JS001 For Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma (1)

Carcinoma | Upper Tract Urothelial Carcinoma | UTUC

China
Fudan University

Recruiting

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Laryngeal Cancer | Hypopharyngeal Cancer

China
The Affiliated Hospital of Xuzhou Medical University

Recruiting

A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

Biliary Tract Cancer

China
Third Military Medical University

Unknown

Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes

Diabetes | Taurine | Lower Extremity Artery Disease

China
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Healthy

Korea, Republic of
Federal University of Health Science of Porto Alegre

Unknown

Effects of TENS in Autonomous System in Women With Overactive Bladder

Urinary Bladder, Overactive

Brazil
Aga Khan University

Unknown

Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive Medication

Hypertension

Pakistan
Shanghai East Hospital
Shanghai Juvensis Therapeutics Biotechnology Company Limited

Recruiting

Myocardial Telomere Recapping Study for Dilated Cardiomyopathy (MERCURY-DCM)

Heart Failure | Dilated Cardiomyopathy

China
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

To Evaluate the Efficacy and Safety of JS002 in HoFH Patients

Hyperlipemia

China
Centre Hospitalier Esquirol
Direction Générale de l'Offre de Soins

Not yet recruiting

Impact of Psychomotor Therapy on the Quality of Life in Depression (PsyMot-Dep)

Major Depressive Disorder

France
Shanghai Junshi Bioscience Co., Ltd.

Terminated

Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Phloronol Inc.
Worldwide Clinical Trials

Completed

Phase I Study of PH100 (Ecklonia Cava Phlorotannins)

Safety Issues

United States
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Japan
Inmagene LLC

Completed

Study to Evaluate IMG-004 in Healthy Participants

Healthy Participants

United States
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Clinical Study of JS201 in Patients With Advanced Malignant Tumors

Patients With Advanced Malignant Tumors

China
Mundipharma Korea Ltd

Completed

A Study Comparing Norspan Patch and Oral Tramadol

Osteoarthritis

Korea, Republic of
Peking University

Recruiting

Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Refractory Metastatic Digestive System Carcinoma

China
Shanghai Junshi Bioscience Co., Ltd.

Completed

Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma (JUPITER06)

Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy

China
Guangxi Medical University
Wuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaborators

Not yet recruiting

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
Fudan University

Not yet recruiting

Newly Emerging Immunotherapy for Pancreatic Cancer Treatment (FD-IMPACT)

Pancreatic Cancer

China
Samsung Medical Center
Dong-A Pharmaceutical Co., Ltd.

Unknown

Zydena on Cognitive Function of Alzheimer's Disease Patients

Alzheimer's Disease

Korea, Republic of
Shanghai Junshi Bioscience Co., Ltd.

Not yet recruiting

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

Primary Hypercholesterolaemia and Mixed Dyslipidemia

China
Shanghai Junshi Bioscience Co., Ltd.

Completed

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Hyperlipemia

China
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI

Non-small Cell Lung Cancer

China
Fudan University

Unknown

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Thyroid Cancer

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

China
University of California, Los Angeles

Completed

Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material

Dental Pulp Diseases | Dental Pulp Necrosis | Nerve Root Pain Nec

United States
Schweizer Paraplegiker Forschung

Unknown

Shared Responsibility Between General Practitioners and Highly Specialized Hospitals in Spinal Cord Injury (SCICO)

Spinal Cord Injuries

Switzerland
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaborators

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Hemorrhagic Fever, Ebola

Germany
National Institute of Allergy and Infectious Diseases...
Sanaria Inc.; Malaria Research and Training Center, Bamako, Mali

Completed

Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

Malaria

Mali
University of Minnesota

Recruiting

Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder (MOPSO PIGD)

Parkinson Disease

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure

Healthy Volunteers

United States
Universitat de Lleida

Completed

Physiotherapy Re-education of Pre-activation of the Transverse Abdominis in Patients With Chronic Low Back Pain

Chronic Non-specific Low-Back Pain

Spain
Spectrum Dynamics

Withdrawn

Study to Compare a Fast Gama Camera for Nuclear Imaging to Conventional Camera (GP_D-Spect)

Detect Pathalogical Lesions

Israel

Search clinical trials for: JS001 120mg GP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations